Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Asbjørn Årøen, University Hospital, Akershus Identifier:
First received: April 17, 2009
Last updated: November 15, 2014
Last verified: November 2014